Position	Rank	AAs	Comment
71	1	TV	A71V/T are polymorphic, PI-selected accessory mutations that increase the replication of viruses with other PI-resistance mutations.
71	2	IL	A71I/L are non-polymorphic, PI-selected accessory mutations that appear to increase the replication of viruses with other PI-resistance mutations.
73	1	STCA	G73S/T/C/A are non-polymorphic accessory PI-selected mutations.  They are associated primarily with reduced susceptibility to ATV, SQV, IDV, and NFV.
10	1	F	L10F is a common non-polymorphic, PI-selected accessory mutation associated with reduced susceptibility to LPV, DRV, FPV, and IDV.
10	2	IV	L10I/V are polymorphic, PI-selected accessory mutations that increase the replication of viruses with other PI-resistance mutations.
10	3	RY	L10R/Y are rare, non-polymorphic PI-selected accessory mutations.  Their effects on PI susceptibility have not been well studied.
74	1	P	T74P is a non-polymorphic PI-selected accessory mutation that occurs primarily in viruses from patients who have received multiple PIs.  It is associated with reduced susceptibility to each of the PIs.  It is included in the Boehringer-Ingelheim TPV and Tibotec DRV GSS.
11	1	I	V11I is a relatively non-polymorphic accessory mutation selected in patients receiving DRV.  It is included in the Tibotec GSS for DRV.
76	1	V	L76V is a non-polymorphic mutation selected by IDV, LPV and DRV.  It reduces susceptibility to these PIs and to FPV and NFV.  It increases susceptibility to ATV, SQV and TPV.  L76V is included in the Tibotec DRV GSS.
82	1	A	V82A is a non-polymorphic mutation selected primarily by IDV and LPV.  It reduces susceptibility to these PIs and contributes cross-resistance to each of the remaining PIs except DRV and TPV.
82	2	TS	V82T/S are non-polymorphic PI-selected mutations.  They are associated with reduced susceptibility to each of the PIs except DRV.  V82T is included in the Boehringer-Ingelheim TPV GSS.
82	3	F	V82F is a non-polymorphic mutation selected primarily by IDV and LPV.  It reduces susceptibility to these PIs and contributes cross-resistance to each of the remaining Pis.
82	4	M	In most subtypes, V82M is a 2-base-pair mutation that develops in viruses with multiple other PI-resistance mutations.  In subtype G, V82M is a 1-base-pair mutation.  V82M reduces susceptibility to IDV, LPV and possibly other PIs.
82	5	L	V82L is an uncommon non-polymorphic mutation selected by TPV.  It reduces TPV susceptibility but its effects on other PIs have not been well studied.
82	6	C	V82C is an uncommon non-polymorphic mutation that occurs primarily in viruses with multiple other PI-resistance mutations.  Its effects on PI susceptibility have not been well studied.
82	7	I	V82I is a highly polymorphic mutation that is not selected by PIs.  It is the consensus amino acid in subtype G viruses.
83	1	D	N83D is a non-polymorphic mutation selected primarily in patients who have received multiple PIs.  It is included in the Boehringer-Ingelheim GSS for TPV.
20	1	T	K20T is a non-polymorphic accessory PI-selected mutation.
20	2	MV	K20M/V are rare, relatively non-polymorphic PI-selected mutations that have not been well studied.
20	3	I	K20I is the consensus amino acid in subtype G and CRF02_AG.  In subtypes B and C, K20I is a PI-selected accessory mutation that reduces NFV susceptibility.
20	4	R	20R is a highly polymorphic PI-selected accessory mutation.
84	1	V	I84V is a non-polymorphic mutation selected by each of the PIs.  It causes high-level resistance to ATV, FPV, IDV, NFV and SQV, intermediate resistance to LPV and TPV, and low-level resistance to DRV.
84	2	AC	I84A is a rare non-polymorphic PI-selected substrate-cleft mutation associated with high-level resistance to each of the PIs.  I84C is a rare non-polymorphic PI-selected mutation associated with varying degrees of reduced susceptibility to each of the PIs.
85	1	V	I85V is a non-polymorphic PI-selected mutation.  It has minimal, if any, effects on PI susceptibility.
23	1	I	L23I is an uncommon non-polymorphic mutation selected primarily by NFV.  It causes low-level resistance to NFV.
24	1	I	L24I is a non-polymorphic mutation selected by IDV and LPV.  It contributes reduced susceptibility to each PI except DRV and TPV.
24	2	F	L24I is a non-polymorphic mutation selected by IDV and LPV.  It contributes reduced susceptibility to each PI except DRV and TPV.  L24F is an uncommon non-polymorphic PI-selected mutation that appears to have a susceptibility profile similar to L24I.
88	1	D	N88D is a non-polymorphic mutation selected by NFV usually in combination with D30N.  It reduces NFV susceptibility and may cause low-level cross-resistance to ATV and SQV.
88	2	S	N88S is a non-polymorphic mutation usually selected by NFV, ATV, or IDV.  It causes high-level resistance to NFV and ATV and low-level resistance to IDV and SQV.  It increases susceptibility to FPV.
88	3	TG	N88G/T are extremely rare non-polymorphic PI-selected mutations that reduce susceptibility to NFV and ATV.
89	1	V	L89V is a non-polymorphic PI-selected accessory mutation which contributes reduced susceptibility to FPV and DRV.  L89V is included in the Tibotec DRV GSS.
90	1	M	L90M is a non-polymorphic PI-selected mutation which reduces susceptibility to each of the PIs except TPV and DRV.
30	1	N	D30N is a non-polymorphic mutation that causes high-level resistance to NFV.
32	1	I	V32I is a non-polymorphic PI-selected mutation associated with reduced susceptibility to each PI except SQV.  It is included in the Tibotec DRV GSS.
33	1	F	L33F is a relatively non-polymorphic accessory mutation selected by DRV, FPV, LPV, NFV and TPV.  In combination with other PI-resistance mutations, it is associated with reduced susceptibility to these PIs.  It is included in the Tibotec DRV GSS.
43	1	T	K43T is a non-polymorphic PI-selected accessory mutation.  K43T is included in the Boehringer-Ingelheim GSS for TPV.
46	1	IL	M46I/L are relatively non-polymorphic PI-selected mutations.  In combination with other PI-resistance mutations, they are associated with reduced susceptibility to each PI except DRV.
46	2	V	M46I/L are relatively non-polymorphic PI-selected mutations.  In combination with other PI-resistance mutations, they are associated with reduced susceptibility to each PI except DRV.  M46V is a rare non-polymorphic PI-selected mutation that has not been well studied.
47	1	V	I47V is a non-polymorphic PI-selected mutation associated with reduced susceptibility to each of the PIs except SQV and ATV.  I47V is included in the Tibotec DRV GSS.
47	2	A	I47A is a non-polymorphic mutation selected by LPV.  It usually occurs in combination with V32I and in this context it confers high-level resistance to LPV and FPV and low/intermediate-resistance to the remaining PIs except ATV and SQV.
48	1	V	G48V is a non-polymorphic mutation selected by SQV and, less often, by IDV and LPV.  It confers high-level resistance to SQV, intermediate resistance to ATV, and low-level resistance to NFV, IDV and LPV.
48	2	M	G48V is a non-polymorphic mutation selected by SQV and, less often, by IDV and LPV.  It confers high-level resistance to SQV, intermediate resistance to ATV, and low-level resistance to NFV, IDV and LPV.  G48M is a non-polymorphic mutation selected in patients who have received multiple PIs.  Its effects appear to be similar to those of G48V.
48	3	ASTQL	G48V is a non-polymorphic mutation selected by SQV and, less often, by IDV and LPV.  It confers high-level resistance to SQV, intermediate resistance to ATV, and low-level resistance to NFV, IDV and LPV.  G48M is a non-polymorphic mutation selected in patients who have received multiple PIs.  Its effects appear to be similar to those of G48V.  G48A/S/T/Q are rare non-polymorphic mutations selected in patients who have received multiple PIs.
50	1	L	I50L is a non-polymorphic mutation selected by ATV.  It causes high-level resistance to ATV and increases susceptibility to the remaining PIs.
50	2	V	I50V is a non-polymorphic mutation selected by DRV, LPV and FPV.  It causes low-level, intermediate, and high-level resistance to DRV, LPV, and FPV, respectively.  It is included in the Tibotec DRV GSS.
53	1	L	F53L is a non-polymorphic accessory PI-selected mutation which reduces susceptibility primarily to ATV, SQV, and NFV.
54	1	V	I54V is a non-polymorphic PI-selected mutation which contributes reduced susceptibility to each of the PIs except DRV.
54	2	ATS	I54A/T/S are non-polymorphic PI-selected mutations that occur almost exclusively in patients who have received multiple PIs.  I54A/T/S are associated with reduced susceptibility to each of the PIs except DRV.
54	3	LM	I54M/L are non-polymorphic mutations selected primarily by DRV and FPV.  I54M reduces susceptibility to each of the PIs.  I54L reduces susceptibility to each of the PIs except TPV.  I54M/L are each included in the Tibotec DRV GSS.
58	1	E	Q58E is a non-polymorphic accessory PI-selected mutation associated with reduced susceptibility to TPV and possibly other PIs.

